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1    Introduction
The processing, or manufacture, of hematopoietic stem 
cells (HSCs) for therapeutic application has made signifi-
cant progress in recent years. In the field of HSC trans-
plant successful strategies have been developed for the 
use of expanded cell populations in support of an unex-
panded unit to reduce time for myeloid recovery [1]. 
Emerging research suggests a single expanded cell popu-
lation may soon be a viable treatment option [2]. Success 
is also being achieved with genetically modified hemat-
opoietic cells for treating rare genetic abnormalities such 
as Wiskott-Aldrich syndrome or Adenosine deaminase 
deficiency [3–5]. Early stage research promises manufac-
ture of mature lineage cells such as erythrocytes or plate-
lets from progenitors. Wider adoption of such therapies 
will require scalable and controllable processes within the 
constraints of economic delivery.
A common factor in the manufacture of therapeutic 
cells is the reliance on soluble signaling factors, such as 
cytokines, to control growth and differentiation out-
comes; current cell culture protocols primarily consist of 
defined cocktails of soluble factors. However, the use of 
soluble factors has limitations including rapid decay and 
homogenous dispersion in culture [6]. This prevents pres-
entation of high concentrations of factor at the receptor 
relative to bulk distribution (reducing effective potency), 
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and presentation of several discrete combinations of fac-
tors simultaneously to generate multiple microenviron-
ments within a bulk culture. It also prevents recycling of 
active GFs independently from other factors in the milieu 
[7, 8]. Collectively these drawbacks reduce opportunities 
to decrease costs, of which media volume and supple-
mented factors form a substantial part, and hinder the 
development of more refined GF strategies to exert control 
over proliferation, commitment and heterogeneity of cell 
populations.
Surface adhered GFs are an alternative culture strat-
egy to soluble. In vivo, a number of GFs (e.g. SCF and 
Flt-3L) can exist in both soluble and matrix (or membrane) 
bound forms [9, 10]. Matrix bound GFs associate with 
glycosaminoglycans (heparin or heparan sulfate) or pro-
teins of the extracellular matrix (ECM) including fibronec-
tin and collagen [7, 11]. Immobilization of GFs in vitro 
allows high localized concentrations of factor combina-
tions which can induce synergetic signaling through 
mechanisms such as ligand multivalency and receptor 
clustering; this has been suggested to lead to distinct 
signaling pathways in comparison to their soluble coun-
terparts [12]. Further, proteins such as SCF and Notch-1 
ligand have distinct functional effects depending on their 
soluble or bound state [13–17]. Other functional attributes 
reported for iGFs include increased potency, prolonged 
response, and protection from proteolytic degradation 
and receptor-mediated endocytosis [18–21]. Immobiliza-
tion of proteins within a culture system therefore has the 
potential to offer more control opportunities than soluble 
factors alone. 
Achieving controlled cell fate outcomes from iGF is 
dependent on a suitably well mixed system, an appropri-
ate mechanism of immobilization, and that the cell/iGF 
interaction will predictably scale. Soluble growth factors 
(sGF) will diffuse down a concentration gradient in a non-
mixed or poorly mixed system; conversely iGF have a 
fixed locus leading to potentially heterogeneous exposure 
of individual cells. To address these criteria we have 
developed an immobilization strategy that is amenable to 
incorporation in a stirred tank bioreactor format. Immobi-
lization of GFs in a culture process could be achieved via 
a wide range of methods and these are described compre-
hensively elsewhere [22]. The immobilization method 
selected was based on a Streptavidin coated surface 
treated with a biotinylated version of the GF of interest 
with a PEG linker between the biotin and the GF. This 
system has a number of attractive attributes including: 
click chemistry under benign reaction conditions, re-
agents compliant with clinical use, and the potential to 
tune steric presentation of GFs. To achieve scalability we 
immobilized onto magnetic particles that could be dis-
tributed at a controlled surface to volume ratio in a stand-
ard stirred tank bioreactor format. Such a culture format 
has extensive literature supporting control of culture 
conditions and scalability [23–24]. Further the magnetic 
properties enabled temporal control of GF exposure inde-
pendently of the bulk medium. This approach enabled us 
to demonstrate functionality and selective temporal con-
trol of key clinically relevant hematopoietic factors 
GMCSF, SCF and TPO in a scalable production system.
2    Materials and methods
2.1    Growth factor immobilization 
The immobilization method involves a two-step reaction: 
2.1.1  Step 1 – Growth factor biotinylation 
1.1.  Lyophilized carrier free GFs (R&D Systems, UK) 
were re-suspended in PBS at a concentration of 
50 µg/mL. 
1.2.  NHS-PEG2000-biotin (Nanocs Inc., USA) was sus-
pended in anhydrous DMSO at the required 
molar concentration for the individual experi-
ment being carried out and used immediately.
1.3.  Equal volumes of GF and NHS-PEG2000-biotin 
were mixed in LoBind Protein Eppendorf tubes 
and vortexed for 2 h at room temperature.
2.1.2  Step 2 - Immobilization of biotinylated growth 
factors
2.1.  2.8  µm streptavidin coated magnetic particles 
(Solulink, USA) were placed on a magnetic stand 
(MagnaRack™ Magnetic Separation Rack, 
 ThermoFisher Scientific) and the supernatant 
removed. 
2.2.  Biotinylated GF solution from step 1.3 was added 
to the prepared particles and vortexed overnight 
at 4–8 ºC.
2.3.  iGFs were washed three times in 500 µL of PBS 
using a magnetic stand and used immediately. 
2.2    Quantification assays
2.2.1 Immobilized growth factor concentration
2  ×  105  iGF particles were incubated in 50  µL of flow 
cytometry stain buffer containing the required concentra-
tion of conjugated monoclonal antibodies (R&D Systems, 
UK) for 1 h at room temperature. Where conjugated anti-
bodies were unavailable, antibodies were custom conju-
gated using an APC-Antibody conjugation kit (Solulink, 
USA). In parallel, iGF particles were also stained with an 
antibody isotype control. iGF particles were then washed 
once with PBS and re-suspended in 100–500 µL of PBS. 
Fluorescence intensity was measured using FACS 
Canto II flow cytometer (BD Biosciences, UK) by taking a 
minimum of 10 000 events at medium flow rate. Fluores-
cence reference standards (Quantum MESF; Bangs Labs 
Inc., USA) were run on the same day to determine the 
mean mass of GF per particle using the net geometric 
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mean of fluorescence intensity (sample geometric mean 
minus isotype geometric mean). 
2.2.2  Soluble growth factor concentration
Soluble GF concentrations were determined with a Bio-
Plex Magpix Multiplex Reader (Bio-Rad Laboratories, UK) 
using pre-mixed Human Magnetic Luminex assay kits 
with SCF and GMCSF analytes (R&D Systems, UK). Cell 
culture media were stored at -20°C until use.
2.2.3  Determination of particle number
Particle number was determined using the particle count 
setting of an automated cell counter, Countess (Ther-
moFisher, UK). Final particle concentration was deter-
mined using flow cytometry where a fixed volume of 
sample was analyzed using medium flow rate. Flow 
cytometry data was analyzed using FlowJo software 
(Treestar, USA) and cells/mL was generated from the 
particle population gate. 
2.3    Functional assays
2.3.1  TF1 cell proliferation assay
TF1 cells (ATCC, UK) were maintained in culture at a 
density of 2  ×  105 to 8  ×  105  cells/mL with media and 
GMCSF replenishment every two to three days [25]. 
Media consisted of RPMI 1640 (phenol red and glutamine 
free; ThermoFisher Scientific), 10% v/v FBS (Life Tech-
nologies), 5 mM Glutamax (ThermoFisher Scientific) and 
5 ng/mL carrier free GMCSF (R&D Systems).
Unless otherwise stated, TF1 cells were washed three 
times in GMCSF free media and starved of GMCSF for 
24  h. Either soluble GMCSF (sGMCSF) or immobilized 
GMCSF (iGMCSF) was supplemented to starved TF1 cells 
and a growth rate was determined thereafter using flow 
cytometry. 
2.3.2  M07e cell proliferation assay
M-07e cells (Creative Biosystems, USA) were maintained 
in culture at a density of 4 × 105 to 1 × 106 cells/mL with 
media, GMCSF and SCF replenishment every two or three 
days. Media consisted of RPMI 1640 (phenol red and glu-
tamine free), 10% FBS v/v, 5  mM Glutamax, 5  ng/mL 
GMCSF and 10 ng/mL SCF. 
M07e cells were washed three times in GMCSF free 
media and starved of GMCSF for 24 h. Soluble or immobi-
lized GMCSF, SCF and TPO were supplemented individu-
ally to starved M-07e cells and a growth rate was deter-
mined thereafter using absolute cell counts determined 
by flow cytometry. 
2.3.3  Micro-bioreactor TF1 culture
A micro-scale stirred tank bioreactor platform (ambr®; 
Sartorius Stedim, UK.) was used to determine the scalabil-
ity of the immobilization method. Physiochemical param-
eters were set to: 100% DO2 (oxygen delivery), pH  7.4, 
temperature 37 °C, stir speed 350 rpm. Non-sparged ves-
sels were used with 1% antifoam additions (Antifoam C, 
Sigma Aldrich, UK) performed every 24  h beginning at 
0 h. The ambr® was programed to sample from vessels 
every 3 h, dispensing into a microtiter plate containing 
4% paraformaldehyde (Sigma Aldrich, UK) which was 
then analyzed on a flow cytometer to determine cell and 
particle number. A complete media change was per-
formed every 48–72 h and cells were reset to a density of 
2 × 105 cells/mL. 
For iGF conditions, particles were retained within the 
vessel by holding a magnet against the vessel, whilst 
performing media changes. 
2.4    Determination of viable cell number 
2.4.1  Flow cytometry
Cell number was determined by flow cytometry. A fixed 
volume of sample was analyzed using medium flow rate. 
Flow cytometry data was analyzed using FlowJo software 
(Treestar, USA) and cells/mL was generated from the cell 
population gate. 
2.4.2  ViCell
The AMBR was programmed to sample cell suspensions 
every ≈4 h with a two-fold dilution with media to deter-
mine viable cell number using a Vicell (Beckman Coulter), 
an automated trypan blue exclusion method cell counter. 
An average of 50 images per sample was used to deter-
mine viable cell number. 
2.4.3  Determination of population doublings
Population doublings per day were determined using the 
following formula:
population doublings = (log10[FD/SD] × 3.32)
where FD = final density (live cells/mL);  
SD = seeding density (live cells/mL).
2.5    Statistical analysis
To determine the statistical significance of one variable 
between two groups, a student’s two-tailed t-Test was 
performed. To determine the statistical significance of 
one variable between three or more groups a one-way 
ANOVA was performed followed by Dunnett’s test for 
multiple comparisons. To determine the statistical sig-
nificance of two variables between three or more groups 
a two-way ANOVA was performed followed by Sidak’s 
test for multiple comparisons. 
For all tests a P  ≤  0.05 was deemed significant. All 
statistical tests were performed using GraphPad Prism 6 
(GraphPad Software Inc., USA). 
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3    Results 
3.1     Immobilization and control of surface 
concentration of growth factors
A series of experiments were conducted to determine 
the effect of reagent concentrations on GF binding to the 
streptavidin coated beads. Target GFs were biotinylated 
via reaction of an NHS group on the biotin-PEG2000-NHS 
with primary amines of the lysine residues in the GF 
(Fig. 1, step 1). Initially we determined the effect of alter-
ing the molar ratio of biotin-PEG2000-NHS to lysine resi-
dues in the target GFs. It was anticipated that biotin–
PEG2000-NHS in excess of a 1:1 ratio with target lysine 
would result in free-biotin being carried forward to 
competitively blank streptavidin on the particles and 
therefore reduce GF-biotin bound to the particles, whilst 
below a 1:1 biotin-PEG2000-NHS to lysine ratio the num-
ber of biotinylated GFs available in the particle binding 
step would become a limiting factor (Fig. 1, step 2). In 
accordance with this, maximum surface yields of three 
GFs (GMCSF, SCF and TPO) were achieved by using the 
equivalent biotin-PEG2000-NHS molarity to the number 
of lysine residues within the GF (Fig.  2A). This is a 
potentially simple mechanism to control surface concen-
tration of iGF.
The absolute concentration of biotin–PEG2000-NHS 
and GF during GF biotinylation (Fig. 1, step 1), at a fixed 
Figure 1.  Immobilization of growth fac-
tors onto streptavidin functionalized 
microparticles. The immobilization 
method consists of a two-step reaction. 
In step 1, the GFs primary amines react 
with the NHS terminus of a heterobi-
functional PEG molecule, NHS-(PEG)n- 
biotin, to produce a biotinylated GF. 
Once the reaction is complete, streptavi-
din functionalized microparticles are 
added in step 2, allowing the biotin ter-
minus of the biotinylated GF to bind to 
the streptavidin ligands of the micropar-
ticles resulting in immobilization.
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molar ratio of 1:1 biotin-PEG2000-NHS to lysine residues, 
was evaluated to determine its relationship with the sub-
sequent immobilized surface concentration. Surface con-
centration of iGF approached saturation at 200 µg/mL of 
soluble GF (sGF) (Fig. 2B). The relationship between the 
concentration of sGF and iGF per particle should theo-
retically be sigmoidal (R2 of sigmoidal line = 0.98 for 
GMCSF and SCF) presuming the mechanism under pin-
ning this is NHS degradation via hydrolysis at a constant 
rate and a rate of NHS binding with GF that is propor-
tional to reagent concentration [26]. This presents a com-
plementary method to manipulate immobilized surface 
concentration and indicates the importance of controlling 
factors that influence reaction kinetics to achieve repro-
ducible results. GF concentrations of 50 µg/mL were tak-
en forward for particle preparation for functional studies; 
this utilized approximately 25% of the total GF presenta-
tion capacity of the beads.
The benefits of ligand co-signalling may require pro-
duction systems to co-present two or more GFs on a sin-
gle particle in controlled relative concentrations. It was 
hypothesized that if multiple biotinylated GFs at equal 
concentrations were incubated with the particles (Fig. 1, 
step 2) the relative bound surface concentrations would 
be determined by lysine residue number (and therefore 
biotinylated sites available for streptavidin binding). The 
Figure 2. Methods for controlling surface concentration of immobilized growth factors. (A) The surface concentrations of three growth factors were con-
trolled by regulating the NHS-(PEG)n-biotin (biotin) molar excess during step 1 of the immobilization reaction. Maximum surface concentrations were 
achieved with a 1:1 biotin to lysine molar ratio for each of the growth factors investigated (n = 3 mean ± SD). (B) The effect of soluble GF-biotin concentra-
tion at optimal GF:biotin molar ratios were investigated to regulate the surface concentration of immobilized growth factors. A sigmoidal relationship 
between soluble GF-biotin and iGF concentration for (i) GMCSF and (ii) SCF (n = 3 mean ± SD). (C) The immobilization preferences for a mixture of two 
or more growth factors at equal molar concentrations were investigated. (i) The preference for immobilization was SCF>GMCSF>TPO from high to low (ii) 
Binding preference was linked to the residual lysine number of the growth factor (iii) A linear relationship between lysine number and concentration of 
immobilized GF was shown (n = 3).
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three GFs (GMCSF, SCF and TPO) mixed at equal concen-
trations, either in pairs or all three, resulted in surface 
binding of each GF in proportion to its lysine content 
(SCF>GMCSF>TPO) with a high degree of linear correla-
tion (R2 > 0.98; Fig. 2C). These indicated relative surface 
concentrations could be controlled via compensating for 
different lysine residues with changes in GF concentra-
tion.
3.2     Functionality, stability, and manipulation  
of immobilized GMCSF in a non-mixed culture 
system
Following demonstration that GFs could be effectively 
immobilized at controlled surface concentrations we 
sought to demonstrate iGFs retained functionality. Fur-
ther, we aimed to show iGFs could be manipulated inde-
pendently of the bulk media with the use of magnets and 
retain prolonged functionality.
The functional activity of iGMCSF was investigated 
using a GMCSF dependent cell line, TF-1. A dose-response 
of sGMCSF and iGMCSF was compared to determine the 
relative response of TF-1. sGMCSF reached a maximal 
response at approximately 2 ng/mL in accordance with 
prior studies (Fig. 3A) [25]. iGMCSF created at very low 
surface concentrations (0.008–0.09 fg/bead) stimulated a 
linear increase in growth rate with a logarithmic increase 
in particle concentration, matching the soluble response 
at approximately 1 × 105 particles/mL at 0.09 fg/particle or 
0.009 ng/mL (Fig. 3Bi). Conversion of the different particle 
concentrations and surface concentrations into total iGF 
presented per mL allowed calculation of a single dose 
Figure 3.  Functionality, stability, and manipulation of immobilized GMCSF in a non-
mixed culture system. (A) Dose-response of soluble GMCSF in a GMCSF dependent 
cell line, TF-1. Maximal response is achieved with 2–10 ng/mL of soluble GMCSF 
(n = 5 ± SD). (B) (i) The response of TF-1 cells to a range of immobilized GMCSF sur-
face concentrations and particle concentrations were investigated. The maximum solu-
ble response was achieved with 1 × 105 particles/mL at a surface concentration of 
0.09 fg/particle (ii) Particle concentration and surface concentration were converted to 
total immobilized GMCSF/mL to construct a single dose-response curve. The maxi-
mum immobilized response is achieved with 10 pg/mL of immobilized GMCSF (n = 3). 
(C) The effects of a single dose of immobilized GMCSF (0.3 ng/mL) retained through-
out the culture period was investigated in comparison to a soluble control (soluble 
GMCSF was replaced every 48 h at media change – vertical dashed lines). The cell 
growth rate for the immobilized and soluble GMCSF conditions were equivalent for the 
experimental duration of 192 h over three media exchanges (n = 2 ± SD).
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response (Fig.  3Bii). This indicated a maximal immobi-
lized dose response of approximately 1–10 pg/mL, some 
three orders of magnitude more potent than the soluble 
equivalent. The formation of a relatively unified dose 
response curve from a range of different surface and par-
ticle concentrations suggest modulation of either surface 
concentration or particle number can be used to alter 
concentration of presented GF to a similar degree.
The functional stability of iGMCSF was tested by cul-
ture of TF-1 cells with a single set of GMCSF coated par-
ticles magnetically retained through serial bulk medium 
changes in a static system. A positive control was treated 
with a media exchange containing sGMCSF every 48 h; a 
negative control had no GMCSF. The cell growth rate for 
the iGMSCF and sGMCSF conditions were equivalent for 
the experimental duration of 192  h over three media 
exchanges (Fig. 3C). The surface concentration of iGMCSF 
was 1.56 fg/particle (or 0.3 ng/mL at 2 × 105 particles/mL) 
equivalent to a 94% decrease in total GF required to 
stimulate the maximal biological response. Including the 
three media changes the immobilized culture used 1.5% 
of the GF over the 192 h relative to the soluble control. 
sGMCSF concentration was monitored in all experimen-
tal systems via Magpix™ analysis to confirm no sGF 
leached from the immobilized system. 
3.3     Functionality, stability, and manipulation  
of immobilized GMCSF in stirred tank 
bioreactors and effects of transient exposure  
to growth factor
The method presented can theoretically be scaled using 
surface area (particle number) to volume ratio in a suspen-
sion culture; we therefore aimed to validate the functional 
activity of iGMCSF under mechanical agitation in a 
micro-scale stirred tank bioreactor system (ambr®). Fur-
ther, we proposed that continuous exposure of GF is 
unnecessary, or may have negative effects for continuous 
cell growth [27–28].
TF-1 cells were cultured in the ambr® system over 120 h 
with either sGMCSF or iGMCSF. Under stirred conditions 
the cells responded equivalently to continual exposure of 
both sGMCSF and iGMCSF over the 120 h, indicating agi-
tation of the cells/particles was not a barrier to contact and 
signaling, and iGMCSF retained functionality over an 
extended period (Fig. 4A). At sequential time intervals after 
initiation of culture, GF was withdrawn to determine if 
stimulation and decay of cell growth was equivalent for 
GMCSF in both soluble and immobilized forms. Continued 
cell growth was observed for a significant time period after 
removal of sGMCSF or iGMCSF, however the duration and 
magnitude of growth was dependent on time of exposure 
and form of presentation (Fig. 4A). Cell growth measured at 
50 h showed a significantly (P = 0.01–0.05) higher response 
than had been achieved with short exposure (2 and 4 h) to 
iGMCSF compared to equivalent short exposure to sGF 
(Fig. 4B). Similarly, cell numbers continued to significantly 
increase (P ≤ 0.05) for a longer period after a short exposure 
(2 and 4 h) to iGMCSF compared to the equivalent exposure 
to sGMCSF (Fig.  4C). iGMCSF concentrations used 
throughout the experiment were calculated to be equiva-
lent to 0.4 ng/mL.
3.4     Functionality and dose response  
of immobilized GMCSF, SCF and TPO
The nature of the GF immobilization through lysine 
groups could potentially lead to reduced activity if the 
binding interfered with active site or induced conforma-
tional change. We therefore determined the functionality 
and dose-response of iGMCSF, iTPO and iSCF using an 
alternative cell line, M-07e, with relevant growth sensitiv-
ity to these GFs. 
Both SCF and TPO GFs also remained biologically 
active once immobilized (Fig. 5). GMCSF and TPO both 
significantly exceeded the maximum sGF response 
(P  ≤  0.0001) whereas SCF did not achieve the soluble 
response despite reaching the top of a response curve. 
Maximum responses were achieved with 2.32 × 104 par-
ticles/mL (1.4 fg/particle) for GMCSF, 2.65 × 104 particles/
mL for TPO, and 8.42 × 106 particles/mL (1.9 fg/particle) 
for SCF (Fig.  5). Negative effects on cell viability were 
observed for highest concentrations of GMCSF and TPO 
(>5.35 × 104 and >8.82 × 104 particles/mL respectively). In 
this cell line 0.003  ng/mL of iGMCSF was required to 
accomplish the maximum soluble response achieved 
using 10 ng/mL of sGMCSF, providing a similar orders of 
magnitude potency gain to that observed in the TF-1 line. 
Additionally, 16 ng/mL of iSCF accomplished 65% of the 
maximum response achieved with 200  ng/mL of sSCF. 
This is consistent with literature indicating distinct roles 
for soluble and bound SCF [14, 15]. A single point concen-
tration experiment with immobilized IL-3 showed that 
0.0059 ng/mL (± 0.00069 ng/mL) of immobilized IL-3 pro-
duced approximately the same growth response (0.32 PD/
day ± 0.0091 StDev) as 0.1 ng/mL soluble IL-3 (0.34 PD/
day ± 0.011 StDev).
4    Discussion 
An approach for incorporating iGF or other proteins into 
scalable suspension cell culture systems has been devel-
oped. The method enables significant reduction in the 
total quantity of some GFs required to produce a func-
tional response relative to a soluble system. Further it 
allows control of local surface GF concentration as well as 
bulk GF concentration. The magnetic component of the 
particles allows complex temporal profiles of GF presenta-
tion independent from changes in the bulk media. The 
iGF appear to display alternate kinetics with respect to 
stimulation and decay of function. In concert these prop-
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erties provide a platform for cost reduction and increased 
control in manufacture of complex GF dependent cell 
systems such as those being developed for haematopoi-
etic products or broader cell therapies.
Multiple GF immobilization methodologies are avail-
able. The important criteria for the proposed application 
are compatibility with clinical grade production, function-
ality, controllability and economics. The GF immobiliza-
tion technique retains biological function in three differ-
ent GFs. Although it is possible that some of the iGF is 
inactive or unavailable depending on the orientation of 
binding, quantification suggests that despite such theo-
retical concerns a large potency and economic gain is 
realizable through this approach to immobilization and 
recycling. The immobilization method has the potential 
for other protein targets important in hematopoietic cell 
expansion including Notch ligands, Wnt ligands and inte-
grins [29]; this provides an opportunity to recapitulate 
some surface presented aspects of the stem cell niche in 
simple and well-mixed scalable systems and control a 
wider range of biological outcomes. The compatibility of 
the approach with agitated and well mixed systems is a 
key criterion; it ensures that particle-cell interactions 
should controllably scale and incorporates the advantages 
of spatially homogenous control of factors such as pH and 
dissolved gasses.
Figure 4.  Functionality, stability, and 
manipulation of immobilized GMCSF in 
stirred tank bioreactors and effects of 
transient exposure to growth factor. 
(A) The effects of immobilized and solu-
ble GMCSF exposure time on subse-
quent TF1 cell growth rates were investi-
gated in an agitated scalable cell culture 
bioreactor. Identical cell growth rates 
were achieved with continuous exposure 
to immobilized and soluble GMCSF 
(n = 2 ± SD). Vertical dashed line repre-
sents the time of a full media passage 
and cell reset to initial seeding density. 
(B) A comparison of cell growth rates at 
a single time-point from (A) (50 h) for 
immobilized and soluble GMCSF were 
investigated. Cell growth was signifi-
cantly increased at 2 and 4 h of expo-
sure to immobilized GMCSF when com-
pared to soluble GMCSF (n = 2 ± SD). 
Single asterisks represents a P value of 
0.01–0.05. (C) The period of sustained 
cell growth following growth factor 
removal was calculated from (A). A sig-
nificant increase in the sustained cell 
growth was achieved with 2 and 4 h of 
exposure to immobilized GMCSF 
(n = 2 ± SD). Single asterisk represents 
a P value of 0.01–0.05.
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The demonstrated capability to control the surface 
presentation of iGFs allows the concentration and ratio of 
GFs to be tailored depending on the required functional 
response. The importance of spatial presentation of GFs 
for distinct functional responses has been reported, par-
ticularly in T-cell signaling [20]. This property of the sys-
tem therefore increases the ability to tailor particles to 
different cell types and specific outcomes. iGF removal is 
also an important consideration for an economic intensi-
fied production system; the increased frequency of bulk 
media exchange with higher cell density (due to exhaus-
tion of other medium components or build-up of toxic 
metabolites) will increase the potential cost impact of 
separating expensive GFs with alternate dynamics. For 
example, if a GF is subject to decay with time in the reac-
tor, potentially cell mediated, presenting the GF intermit-
tently for 2 h would allow more specific productivity per 
GF than constant exposure. GMCSF data suggest that 
some GFs could be effective with particle concentrations 
in the order of 103/mL given a suitably high surface con-
centration, providing further opportunity to reduce cost 
through minimizing particle use. The biological basis for 
the difference between iGF and sGF was not determined. 
However, there is a strong literature base indicating the 
potency and signaling longevity enhancements could be 
due to high local concentration of GF on the particles 
through mechanisms such as receptor multivalency and 
clustering [12, 30–32]. Short interaction times (50  ms) 
between enzyme and substrate are reported providing a 
basis for transient exposure sustaining cell growth [33]. It 
is also possible, given the extremely high potency, that 
some particle carry over could lead to sustained growth 
Figure 5.  Functionality and dose response of immobilized GMCSF, SCF and TPO. The function and dose-response of three immobilized growth factors 
were investigated in a multi-factor dependent cell line (M-07e). All three factors remain biologically active once immobilized. Immobilized GMCSF and 
TPO both significantly exceed the maximal soluble response whereas SCF did not achieve the maximal soluble response. Where quantified, data points are 
labelled with total quantity of immobilized growth factor (n = 3 ± S.D.). * P = 0.01–0.05, **P = 0.001–0.01, ***P = 0.0001–0.001.
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after particle removal; monitoring particle carry over via 
flow cytometer indicated greater than 98% removal effi-
ciency. Such a phenomenon would also not explain the 
observation that time of exposure to iGF had a ‘U-shaped’ 
relationship with growth response.
In conclusion, we have demonstrated a versatile and 
scalable technology for controlling iGF presentation in 
suspension cell culture platforms. The immobilization 
technique has economic and environmental benefits over 
soluble equivalents due to significant reductions of some 
GF quantities required to induce the maximal biological 
response and ability to recycle GFs independently from 
other bulk media components. The distinct functional 
effects of immobilizing GF and control potential of this 
system will allow more regulated engineering of complex 
GF dependent cell culture systems. 
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